Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.04 - BRAIN REORGANISATION AND RECOVERY P253 - ESOC25-737 INVESTIGATING THE ROLE OF MICROGLIA-T CELL CROSSTALK IN THE LONG-TERM SEQUELAE OF ISCHEMIC STROKE Chantal Dembech 1 , Julien Serrier 1,2 , Damien Levard 1 , Myriam Abioui-Mourgues 1 , Romain Goy 1 , Gizem Ocal 1 , Maxence Plateau 1 , Veronique Agin 1 , Denis Vivien 1 , Olivier Toutirais 1,2 , Marina Rubio 1 1 Normandie University, UNICAEN, Institute Blood and Brain @Caen-Normandie (BB@C), INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND)GIP Cyceron, Caen, France, 2 Laboratory of Immunology and Histocompatibility Caen University Hospital, Caen, France Background and Aims: Many survivors of ischemic stroke (IS) not only face physical disability but also delayed onset of symptoms, such as post-stroke depression, fatigue, and memory loss
These models are notoriously poor predictors of human stroke-drug success, which is the single most important reason to treat even elegant positive results with caution
This regulation positively affects other hormones like cortisol, reducing stress and promoting a balanced mood
Injection technique with 5mg vials Drawing the dose Reconstituted with 2ml water (2,500mcg/ml): 250mcg = 10 units 500mcg = 20 units Process : Wipe vial top with alcohol Draw air into syringe (same amount as dose) Inject air into vial Invert vial Draw solution slowly Remove needle, check for air bubbles Tap syringe to remove bubbles Injection sites Best locations for subcutaneous injection: Abdomen (2 inches from belly button) Front of thigh Back of upper arm (harder to self-inject) Site-specific injection (optional): Can inject near injury site for localized effect
Antioxidants (2021) 10:201
